Dr Andrew Yam is an early-career medical researcher in the Innate and Tumour Immunology laboratory, School of Biotechnology and Biomolecular Sciences, UNSW, and Immune Biotherapies Program, Garvan Institute of Medical Research . Andrew is also a consultant clinical medical oncologist at The Kinghorn Cancer Centre, St Vincent’s Hospital, Sydney, treating solid tumours, and is a sub-investigator for multiple phase 1-3 clinical trials. 

Andrew completed undergraduate studies at UNSW and his postgraduate medical degree at the University of Sydney. After obtaining this Fellowship at the Royal Australasian College of Physicians (FRACP).  Andrew completed his PhD at the Innate and Tumour Immunology Lab under the supervision of A/Prof Tatyana Chtanova. His PhD explored the role of microbial infections had in converting the tumour microenvironment from a chronic to acute inflammatory response. He developed and tested the bioparticle therapy in pre-clinical cancer models, and the results of this work were published in Yam et al. ( 2023) Cancer Research. Andrew’s current research is harnessing the anti-cancer microbial inflammation to fight cancers and protect against tumour recurrence with currently used immunotherapies and chemotherapies.  Andrew’s research is supported by the Phil Salter Immuno-oncology Fellowship, UNSW Triple-I seed grant, St Vincent’s Clinic Research Foundation Grant, and Estee Lauder Breast Cancer award.